Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to no vaccination or standard three and two-dose vaccination regimens: A systematic review of evidence from clinical trials

The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164 · see citing works

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): Final analysis of a double-blind, randomised study in young women

Paavonen, J., Naud, P., Salmerón, J., Wheeler, C., Chow, S.-N., Apter, D., Kitchener, H., Castellsague, X., Teixeira, J., Skinner, Sr., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61248-4 · Cited by 1,655 · see citing works

Global Burden of Human Papillomavirus and Related Diseases

Forman, D., de Martel, C., Lacey, C. J., Soerjomataram, I., Lortet‐Tieulent, J., Bruni, L., Vignat, J., Ferlay, J., Bray, F., Plummer, M., et al. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.07.055 · Cited by 1,642 · see citing works

A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women

Joura, E. A., Giuliano, A. R., Iversen, O.-E., Bouchard, C., Mao, C., Mehlsen, J., Moreira, E. D., Ngan, Y., Petersen, L. K., Lazcano-Ponce, E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1405044 · Cited by 1,433 · see citing works

A review of clinical trials of human papillomavirus prophylactic vaccines

Schiller, J. T., Castellsagué, X., & Garland, S. M. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.04.108 · Cited by 747 · see citing works

Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020–99: a modelling study

Simms, K. T., Steinberg, J., Caruana, M., Smith, M. A., Lew, J.-B., Soerjomataram, I., Castle, P. E., Bray, F., & Canfell, K. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30836-2 · Cited by 486 · see citing works

The projected timeframe until cervical cancer elimination in Australia: a modelling study

Hall, M. T., Simms, K. T., Lew, J., Smith, M. A., Brotherton, J. M. L., Saville, M., Frazer, I. H., & Canfell, K. (2018) · The Lancet Public Health · doi:10.1016/s2468-2667(18)30183-x · Cited by 448 · see citing works

Proof-of-Principle Evaluation of the Efficacy of Fewer Than Three Doses of a Bivalent HPV16/18 Vaccine

Kreimer, A. R., Rodríguez, A. C., Hildesheim, A., Herrero, R., Porras, C., SCHIFFMAN, M. H., González, P., Solomon, D., Jiménez, S., Schiller, J. T., et al. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr319 · Cited by 324 · see citing works

Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA trials

Kreimer, A. R., Struyf, F., Rosario‐Raymundo, M. R. D., Hildesheim, A., Skinner, S. R., Wacholder, S., Garland, S. M., Herrero, R., David, M., & Wheeler, C. M. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00047-9 · Cited by 308 · see citing works

Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models

Brisson, M., Bénard, É., Drolet, M., Bogaards, J. A., Baussano, I., Vänskä, S., Jit, M., Boily, M.-C., Smith, M. A., Berkhof, J., et al. (2016) · The Lancet Public Health · doi:10.1016/s2468-2667(16)30001-9 · Cited by 307 · see citing works

Status of HPV vaccine introduction and barriers to country uptake

Gallagher, K. E., LaMontagne, D. S., & Watson‐Jones, D. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.02.003 · Cited by 247 · see citing works

Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort study

Sankaranarayanan, R., Prabhu, P. R., Pawlita, M., Gheit, T., Bhatla, N., Muwonge, R., Nene, B. M., Esmy, P. O., Joshi, S., Poli, U. R. R., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00414-3 · Cited by 242 · see citing works

Durable Antibody Responses Following One Dose of the Bivalent Human Papillomavirus L1 Virus-Like Particle Vaccine in the Costa Rica Vaccine Trial

Safaeian, M., Porras, C., Pan, Y., Kreimer, A. R., Schiller, J. T., González, P., Lowy, D. R., Wacholder, S., SCHIFFMAN, M. H., Rodríguez, A. C., et al. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0203 · Cited by 223 · see citing works

Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16/18 and closely related HPV types

Kavanagh, K., Pollock, K. G. J., Potts, A., Love, J., Cuschieri, K. S., Cubie, H. A., Robertson, C., & Donaghy, M. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.198 · Cited by 185 · see citing works

Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica

Herrero, R., Hildesheim, A., Rodríguez, A. C., Wacholder, S., Bratti, C., Solomon, D., González, P., Porras, C., Jiménez, S., Guillén, D., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.07.002 · Cited by 169 · see citing works

Can a single dose of human papillomavirus (HPV) vaccine prevent cervical cancer? Early findings from an Indian study

Sankaranarayanan, R., Joshi, S., Muwonge, R., Esmy, P. O., Basu, P., Prabhu, P., Bhatla, N., Nene, B. M., Shaw, J., Poli, U. R. R., et al. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.02.087 · Cited by 164 · see citing works

Evidence for single-dose protection by the bivalent HPV vaccine—Review of the Costa Rica HPV vaccine trial and future research studies

Kreimer, A. R., Herrero, R., Sampson, J. N., Porras, C., Lowy, D. R., Schiller, J. T., SCHIFFMAN, M. H., Rodríguez, A. C., Chanock, S. J., Jiménez, S., et al. (2018) · Vaccine · doi:10.1016/j.vaccine.2017.12.078 · Cited by 147 · see citing works

Natural Acquired Immunity Against Subsequent Genital Human Papillomavirus Infection: A Systematic Review and Meta-analysis

Beachler, D. C., Jenkins, G., Safaeian, M., Kreimer, A. R., & Wentzensen, N. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv753 · Cited by 135 · see citing works

Immunogenicity of HPV prophylactic vaccines: Serology assays and their use in HPV vaccine evaluation and development

Pinto, L. A., Dillner, J., Beddows, S. A., & Unger, E. R. (2018) · Vaccine · doi:10.1016/j.vaccine.2017.11.089 · Cited by 114 · see citing works

Durability of Protection Afforded by Fewer Doses of the HPV16/18 Vaccine: The CVT Trial

Safaeian, M., Sampson, J. N., Pan, Y., Porras, C., Kemp, T. J., Herrero, R., Quint, W. G. V., Doorn, L. J. V., Schussler, J. E., Lowy, D. R., et al. (2017) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djx158 · Cited by 91 · see citing works

Human papillomavirus vaccine effectiveness by number of doses: Systematic review of data from national immunization programs

Markowitz, L. E., Drolet, M., Perez, N., Jit, M., & Brisson, M. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.01.057 · Cited by 80 · see citing works

Human papillomavirus 9-valent vaccine for cancer prevention: a systematic review of the available evidence

Signorelli, C., Odone, A., Ciorba, V., Cella, P., Audisio, R. A., Lombardi, A., Mariani, L., Mennini, F. S., Pecorelli, S., Rezza, G., et al. (2017) · Epidemiology and Infection · doi:10.1017/s0950268817000747 · Cited by 74 · see citing works

A Single Human Papillomavirus Vaccine Dose Improves B Cell Memory in Previously Infected Subjects

Scherer, E. M., Smith, R. A. J., Gallego, D. F., Carter, J. J., Wipf, G. C., Hoyos, M., Stern, M. E., Thurston, T., Trinklein, N. D., Wald, A., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.06.042 · Cited by 60 · see citing works

Impact of partial bivalent HPV vaccination on vaccine-type infection: a population-based analysis

Cuschieri, K. S., Kavanagh, K., Moore, C., Bhatia, R., Love, J., & Pollock, K. G. J. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.97 · Cited by 47 · see citing works

Sustained Antibody Responses 6 Years Following 1, 2, or 3 Doses of Quadrivalent Human Papillomavirus (HPV) Vaccine in Adolescent Fijian Girls, and Subsequent Responses to a Single Dose of Bivalent HPV Vaccine: A Prospective Cohort Study

Toh, Z. Q., Russell, F. M., Reyburn, R., Fong, J., Tuivaga, E., Ratu, T., Nguyen, C. D., Devi, R. R., Kama, M., Matanitobua, S., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw865 · Cited by 43 · see citing works

Less than 3 doses of the HPV vaccine – Review of efficacy against virological and disease end points

Basu, P. S., Bhatla, N., Ngoma, T. A., & Sankaranarayanan, R. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2016.1146429 · Cited by 33 · see citing works

Immunogenicity of bivalent HPV vaccine among partially vaccinated young adolescent girls in Uganda

LaMontagne, D. S., Mugisha, E. K., Pan, Y., Kumakech, E., Ssemaganda, A., Kemp, T. J., Cover, J., Pinto, L. A., & Safaeian, M. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.08.071 · Cited by 28 · see citing works

Ending cervical cancer: A call to action

Aranda, S. K., Berkley, S., Cowal, S., Dybul, M. R., Evans, T., Iversen, K., Moeti, M. R., Osotimehin, B., Peterson, S. S., Piot, P. K., et al. (2017) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12182 · Cited by 28 · see citing works

Reduced dose human papillomavirus vaccination: An update of the current state-of-the-art

Toh, Z. Q., Licciardi, P. V., Fong, J., Garland, S. M., Tabrizi, S. N., Russell, F. M., & Mulholland, E. K. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.07.102 · Cited by 25 · see citing works

HPV single-dose vaccination: Impact potential, evidence base and further evaluation

Stanley, M., & Dull, P. M. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.02.076 · Cited by 19 · see citing works

Design and statistical considerations for studies evaluating the efficacy of a single dose of the human papillomavirus (HPV) vaccine

Sampson, J. N., Hildesheim, A., Herrero, R., González, P., Kreimer, A. R., & Gail, M. H. (2018) · Contemporary Clinical Trials · doi:10.1016/j.cct.2018.02.010 · Cited by 14 · see citing works

Antibody persistence after a single dose of quadrivalent HPV vaccine and the effect of a dose of nonavalent vaccine given 3-8 years later – an exploratory study

Gîlca, V., Sauvageau, C., Panicker, G., Serres, G. D., Ouakki, M., & Unger, E. R. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1522469 · Cited by 12 · see citing works

Correction: Durable Antibody Responses Following One Dose of the Bivalent Human Papillomavirus L1 Virus-Like Particle Vaccine in the Costa Rica Vaccine Trial

(2016) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-15-0373 · Cited by 3 · see citing works

Cancer of the cervix uteri: 2021 update

Bhatla, N., Aoki, D., Sharma, D. N., & Sankaranarayanan, R. (2021) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.13865 · Cited by 599 · see citing works

Vaccine efficacy against persistent human papillomavirus (HPV) 16/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre, prospective, cohort study

Basu, P., Malvi, S. G., Joshi, S., Bhatla, N., Muwonge, R., Lucas, E., Verma, Y., Esmy, P. O., Poli, U. R. R., Shah, A., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00453-8 · Cited by 272 · see citing works

Human papillomavirus vaccination and cervical cancer risk

Rahangdale, L., Mungo, C., O’Connor, S., Chibwesha, C. J., & Brewer, N. T. (2022) · BMJ · doi:10.1136/bmj-2022-070115 · Cited by 217 · see citing works

Cervical cancer prevention and control in women living with human immunodeficiency virus

Castle, P. E., Einstein, M. H., & Sahasrabuddhe, V. V. (2021) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21696 · Cited by 212 · see citing works

Vaccine delivery systems toward lymph nodes

Ding, Y., Li, Z., Jaklenec, A., & Hu, Q. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113914 · Cited by 189 · see citing works

National implementation of HPV vaccination programs in low-resource countries: Lessons, challenges, and future prospects

Tsu, V. D., LaMontagne, D. S., Atuhebwe, P. L., Bloem, P. N., & Ndiaye, C. (2021) · Preventive Medicine · doi:10.1016/j.ypmed.2020.106335 · Cited by 174 · see citing works

Therapeutic targets and interventional strategies in COVID-19: mechanisms and clinical studies

Zhou, Y., Xie, Y., Tang, L., Pu, D., Zhu, Y., Liu, J., & Ma, X. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00733-x · Cited by 115 · see citing works

Immunogenicity and Safety Results Comparing Single Dose Human Papillomavirus Vaccine with Two or Three Doses in Tanzanian Girls - the DoRIS Randomised Trial

Watson‐Jones, D., Changalucha, J. M., Whitworth, H. S., Pinto, L. A., Mutani, P., Indangasi, J., Kemp, T. J., Hashim, R., Kamala, B., Wiggins, R. C., et al. (2022) · The Lancet Global Health · doi:10.1016/s2214-109x(22)00309-6 · Cited by 120 · see citing works

Durability of single-dose HPV vaccination in young Kenyan women: randomized controlled trial 3-year results

Barnabas, R. V., Brown, E. R., Onono, M. A., Bukusi, E. A., Njoroge, B. W., Winer, R. L., Galloway, D. A., Pinder, L. F., Donnell, D. J., Wakhungu, I., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02658-0 · Cited by 99 · see citing works

A Framework for Cervical Cancer Elimination in Low-and-Middle-Income Countries: A Scoping Review and Roadmap for Interventions and Research Priorities

Shin, M., Liu, G., Mugo, N., Garcia, P. J., Rao, D. W., Broshkevitch, C. J., Eckert, L. O., Pinder, L. F., Wasserheit, J. N., & Barnabas, R. V. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.670032 · Cited by 84 · see citing works

Advances in the polymeric delivery of nucleic acid vaccines

Chen, G., Zhao, B., Ruiz, E. F., & Zhang, F. (2022) · Theranostics · doi:10.7150/thno.70853 · Cited by 75 · see citing works

Human papillomavirus vaccination in the European Union/European Economic Area and globally: a moral dilemma

Colzani, E., Johansen, K., Johnson, H., & Pastore Celentano, L. (2021) · Eurosurveillance · doi:10.2807/1560-7917.es.2021.26.50.2001659 · Cited by 86 · see citing works

Global impact and cost-effectiveness of one-dose versus two-dose human papillomavirus vaccination schedules: a comparative modelling analysis

Prem, K., Choi, Y. H., Bénard, É., Burger, E. A., Hadley, L., Laprise, J., Regan, M. C., Drolet, M., Sy, S., Abbas, K., et al. (2023) · BMC Medicine · doi:10.1186/s12916-023-02988-3 · Cited by 64 · see citing works

Cancer Prevention in Low-Resource Countries: An Overview of the Opportunity

Kamaraju, S., Drope, J. M., Sankaranarayanan, R., & Shastri, S. S. (2020) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_280625 · Cited by 57 · see citing works

Public health concern-driven insights and response of low- and middle-income nations to the World health Organization call for cervical cancer risk eradication

Reza, S., Anjum, R., Khandoker, R. Z., Khan, S. R., Islam, M. R., & Dewan, S. M. R. (2024) · Gynecologic Oncology Reports · doi:10.1016/j.gore.2024.101460 · Cited by 49 · see citing works

The clinical effectiveness of one-dose vaccination with an HPV vaccine: A meta-analysis of 902,368 vaccinated women

Setiawan, D., Nurulita, N. A., Khoirunnisa, S. M., & Postma, M. J. (2024) · PLoS ONE · doi:10.1371/journal.pone.0290808 · Cited by 45 · see citing works

Evidence-based impact projections of single-dose human papillomavirus vaccination in India: a modelling study

Man, I., Georges, D., de Carvalho, T. M., Ray Saraswati, L., Bhandari, P., Kataria, I., Siddiqui, M., Muwonge, R., Lucas, E., Berkhof, J., et al. (2022) · The Lancet Oncology · doi:10.1016/s1470-2045(22)00543-5 · Cited by 44 · see citing works

Human malignancies associated with persistent HPV infection

McBride, A. A. (2024) · The Oncologist · doi:10.1093/oncolo/oyae071 · Cited by 41 · see citing works

Cervical cancer trends, HPV vaccine utilization, and screening in low- and lower-middle-income countries: an updated review

Hamid, M. K. I., Hasneen, S., Lima, A. K., Shawon, S. R., Shahriar, M., & Anjum, R. (2025) · Therapeutic Advances in Vaccines and Immunotherapy · doi:10.1177/25151355251356646 · Cited by 37 · see citing works

HPV16/18 antibodies 16-years after single dose of bivalent HPV vaccination: Costa Rica HPV vaccine trial

Porras, C., Romero, B., Kemp, T. J., Fantin, R., Herrero, R., Hildesheim, A., Ocampo, R., Sierra, M. S., Gail, M. H., Schussler, J. E., et al. (2024) · JNCI Monographs · doi:10.1093/jncimonographs/lgae032 · Cited by 32 · see citing works

Communication strategies to improve human papillomavirus (HPV) immunisation uptake among adolescents in sub-Saharan Africa: a systematic review and meta-analysis

Oketch, S. Y., Ochomo, E. O., Orwa, J., Mayieka, L., & Abdullahi, L. H. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-067164 · Cited by 30 · see citing works

HPV Vaccination: The Position Paper of the Italian Society of Colposcopy and Cervico-Vaginal Pathology (SICPCV)

Ciavattini, A., Giannella, L., Vincenzo, R. D., Giuseppe, J. D., Papiccio, M., Lukic, A., Carpini, G. D., Perino, A., Frega, A., Sopracordevole, F., et al. (2020) · Vaccines · doi:10.3390/vaccines8030354 · Cited by 28 · see citing works

A protective, single-visit TB vaccination regimen by co-administration of a subunit vaccine with BCG

Dijkman, K., Lindenstrøm, T., Rosenkrands, I., Søe, R., Woodworth, J. S., Arlehamn, C. S. L., & Mortensen, R. J. (2023) · npj Vaccines · doi:10.1038/s41541-023-00666-2 · Cited by 27 · see citing works

Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to multidose vaccination regimens or no vaccination: An updated systematic review of evidence from clinical trials

Whitworth, H. S., Mounier‐Jack, S., Choi, E. M.-L., Gallagher, K. E., Howard, N., Kelly, H. A., Mbwanji, G., Kreimer, A. R., Basu, P. S., Barnabas, R. V., et al. (2024) · Vaccine X · doi:10.1016/j.jvacx.2024.100486 · Cited by 23 · see citing works

Costs of delivering human papillomavirus vaccination using a one- or two-dose strategy in Tanzania

Hsiao, A., Struckmann, V., Stephani, V., Mmbando, D., Changalucha, J. M., Baisley, K. J., Levin, A., Morgan, W., Hutubessy, R. C. W., Watson‐Jones, D., et al. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.11.032 · Cited by 22 · see citing works

Modeling the health and economic implications of adopting a 1-dose 9-valent human papillomavirus vaccination regimen in a high-income country setting: An analysis in the United Kingdom

Daniels, V., Saxena, K., Patterson‐Lomba, O., Gómez-Liévano, A., Saah, A. J., Luxembourg, A. T., Velicer, C. M., Chen, Y., & Elbasha, E. H. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.02.067 · Cited by 21 · see citing works

Acting on the call: A framework for action for rapid acceleration of access to the HPV vaccination in low‐ and lower‐middle‐income countries

Kumar, S., Khanduri, A., Sidibe, A., Morgan, C., Torode, J., Basu, P. S., Bhatla, N., Schocken, C., & Bloem, P. N. (2020) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.13482 · Cited by 20 · see citing works

An Update on Human Papillomavirus Vaccination in the United States

Boitano, T. K. L., Ketch, P. W., Scarinci, I. C., & Huh, W. K. (2023) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000005056 · Cited by 19 · see citing works

The efficacy of vaccination to prevent human papilloma viruses infection at anal and oral: a systematic review and meta-analysis

Zhang, J., Qin, Z., Lou, C., Huang, J., & Xiong, Y. (2021) · Public Health · doi:10.1016/j.puhe.2021.05.012 · Cited by 19 · see citing works

Preventing Cervical Cancer Globally: Are We Making Progress?

Allanson, E. R., & Schmeler, K. M. (2021) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-21-0016 · Cited by 18 · see citing works

Effectiveness of combination therapy with ISA101 vaccine for the treatment of human papillomavirus-induced cervical cancer

Ding, H., Zhang, J., Zhang, F., Xu, Y., Yu, Y., Liang, W., & Li, Q. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.990877 · Cited by 17 · see citing works

Evaluations of water, sanitation and hygiene interventions should not use diarrhoea as (primary) outcome

Watson, S., Rego, R. T. T., Hofer, T. P., & Lilford, R. J. (2022) · BMJ Global Health · doi:10.1136/bmjgh-2022-008521 · Cited by 17 · see citing works

HPV16/18 Antibody Responses After a Single Dose of Nonavalent HPV Vaccine

Zeng, Y., Moscicki, A., Woo, H., Hsu, C., Kemp, T. J., Pinto, L. A., Szabo, E. M., Dimond, E. P., Bauman, J. E., Sahasrabuddhe, V. V., et al. (2023) · PEDIATRICS · doi:10.1542/peds.2022-060301 · Cited by 16 · see citing works

Annual immunisation coverage report 2021 - 14 October 2022

Hull, B. P., Hendry, A., Dey, A., Brotherton, J. M. L., Macartney, K. K., & Beard, F. (2023) · Communicable Diseases Intelligence · doi:10.33321/cdi.2023.47.47 · Cited by 16 · see citing works

Comparison of the safety and persistence of immunogenicity of bivalent HPV16/18 vaccine in healthy 9–14-year-old and 18–26-year-old Chinese females: A randomized, double-blind, non-inferiority clinical trial

Li, J., Shi, L.-W., Li, K., Huang, L., Li, J.-B., Dong, Y.-L., Li, W., Ji, M., Yang, Q. K., Zhou, L., et al. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.10.041 · Cited by 16 · see citing works

If prophylactic HPV vaccination is considered in a woman with CIN2+, what is the value and should it be given before or after the surgical treatment?

Tjalma, W. A. A., van Heerden, J., & WYNGAERT, T. V. D. (2021) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2021.11.008 · Cited by 16 · see citing works

Strong reduction in prevalence of HPV16/18 and closely related HPV types in sexually active adolescent women following the introduction of HPV vaccination in Argentina

González, J. V., Deluca, G., Correa, R. M., Liotta, D. J., Basiletti, J. A., Fellner, M. D., Colucci, M. C., Alzogaray, O. G., Katz, N., Carmona, J. J., et al. (2020) · Papillomavirus Research · doi:10.1016/j.pvr.2020.100208 · Cited by 15 · see citing works

Nationwide introduction of HPV vaccine in Zimbabwe 2018–2019: Experiences with multiple cohort vaccination delivery

Carlton, J. G., Marembo, J., Manangazira, P., Rupfutse, M., Shearley, A., Makwabarara, E., Hidle, A., & Loharikar, A. R. (2022) · PLOS Global Public Health · doi:10.1371/journal.pgph.0000101 · Cited by 14 · see citing works

The Quest to Eradicate HPV-Related Oropharyngeal Carcinoma: An Opportunity Not to Miss

Lalonde, C. S., Teng, Y., Burtness, B. A., Ferris, R. L., Ahmed, R., & Saba, N. F. (2022) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djac098 · Cited by 14 · see citing works

Efficacy and Durability of Immune Response after Receipt of HPV Vaccines in People Living with HIV

Losada, C., Samaha, H., Scherer, E. M., Kazzi, B., Khalil, L. E., Ofotokun, I., & Rouphael, N. (2023) · Vaccines · doi:10.3390/vaccines11061067 · Cited by 14 · see citing works

Human papillomavirus infection and seroprevalence among female university students in Mexico

Pedroza‐González, A., Reyes‐Reali, J., Campos-Solorzano, M., Blancas-Diaz, E. M., Tomás-Morales, J. A., Hernandez-Aparicio, A. A., de Oca‐Samperio, D. M., Garrido, E., García-Romo, G. S., Méndez-Catalá, C. F., et al. (2022) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2022.2028514 · Cited by 14 · see citing works

Global impact and cost-effectiveness of one-dose versus two-dose human papillomavirus vaccination schedules: a comparative modelling analysisPreprint

Prem, K., Choi, Y. H., Bénard, É., Burger, E. A., Hadley, L., Laprise, J., Regan, M. C., Drolet, M., Sy, S., Abbas, K., et al. (2021) · medRxiv · doi:10.1101/2021.02.08.21251186 · Cited by 13 · see citing works

Human papillomavirus vaccine uptake and its determinants among women in Africa: an umbrella review

Mengistie, B. A., Yirsaw, A. N., Lakew, G., Mekonnen, G. B., Shibabaw, A. A., Chereka, A. A., Kitil, G. W., Wondie, W. T., Abuhay, A. E., & Getachew, E. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1537250 · Cited by 12 · see citing works

Prevención de las enfermedades infecciosas. Actualización en vacunas PAPPS 2022

Martín, S. M., Agustí, M. L. M., Miranda, A. P. J., Hernández, C. S., Chavarri, G. S., Herce, P. A., García-Iglesias, C., Marco, J. J. G., & Pérez, M. I. G. (2022) · Atención Primaria · doi:10.1016/j.aprim.2022.102462 · Cited by 11 · see citing works

Effective vaccination strategies for human papillomavirus (HPV) infection and cervical cancer based on the mathematical model with a stochastic process

Kim, M., & Kim, E. (2024) · Journal of Medical Virology · doi:10.1002/jmv.29558 · Cited by 10 · see citing works

HPV Vaccines – An Overview

Ghosh, A., Chatterjee, S., Dawn, A., & Das, A. (2025) · Indian Journal of Dermatology · doi:10.4103/ijd.ijd_805_24 · Cited by 10 · see citing works

HPV vaccination coverage: slightly improved two‐dose schedule completion estimates and historical estimates lower on AIR than HPV Register

Brotherton, J. M. L., Hendry, A., Dey, A., Hull, B. P., & Beard, F. (2022) · Australian and New Zealand Journal of Public Health · doi:10.1111/1753-6405.13233 · Cited by 10 · see citing works

Respiratory Syncytial Virus (RSV) Disease and Prevention Products: Knowledge, Attitudes, and Preferences of Kenyan Healthcare Workers in Two Counties in 2021

Nyawanda, B. O., Opere, V. A., Nyiro, J. U., Vodicka, E. L., Fleming, J. A., Baral, R., Khan, S., Pecenka, C. J., Ayugi, J., Atito, R., et al. (2023) · Vaccines · doi:10.3390/vaccines11061055 · Cited by 9 · see citing works

HPV vaccination leads to decrease of anogenital warts and precancerous lesions of the cervix uteri in young women with low vaccination rates: a retrospective cohort analysis

Osmani, V., Fett, S., Tauscher, M., Donnachie, E., Schneider, A., & Klug, S. J. (2022) · BMC Cancer · doi:10.1186/s12885-022-10214-1 · Cited by 9 · see citing works

Prevalence of Oral Human Papillomavirus Infection by Number of Vaccine Doses Among US Adults

Abel, M. K., Mann, A. K., Sonawane, K., Kapp, D. S., Deshmukh, A. A., & Chan, J. K. (2021) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkab086 · Cited by 9 · see citing works

HPV Infection in Children and Adolescents—A Comprehensive Review

Tomecka, P., Karwowska, A., Kuźnicki, J., Skinderowicz, K., Wojno, A., Markut, K., Typek, P., Ciesielska, U., Kulbacka, J., & Drąg‐Zalesińska, M. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14072425 · Cited by 8 · see citing works

Enhancing equity in cervical screening – initiatives to increase screening participation

Costa, T., Bateson, D. J., & Woo, Y. L. (2024) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000979 · Cited by 8 · see citing works

Prävention HPV-induzierter Erkrankungen durch prophylaktische Impfung

Wieland, U., & Kreuter, A. (2020) · Der Hautarzt · doi:10.1007/s00105-020-04739-4 · Cited by 8 · see citing works

Adolescent Health Series: HPV infection and vaccination in sub‐Saharan Africa: 10 years of research in Tanzanian female adolescents ‐ narrative review

Whitworth, H. S., Changalucha, J. M., Baisley, K. J., & Watson‐Jones, D. (2021) · Tropical Medicine & International Health · doi:10.1111/tmi.13660 · Cited by 8 · see citing works

The one-dose schedule opens the door to rapid scale-up of HPV vaccination

Zou, Z., & Zhang, L. (2023) · BMC Medicine · doi:10.1186/s12916-023-03097-x · Cited by 8 · see citing works

Transforming drug and vaccine delivery for equitable access in global health

Yang, X., Zhang, L., Staykov, K., Wu, Z., & Jaklenec, A. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152415 · Cited by 7 · see citing works

Leveraging single-dose human papillomavirus vaccination dose-efficiency to attain cervical cancer elimination in resource-constrained settings

Man, I., Georges, D., Basu, P. S., & Baussano, I. (2024) · JNCI Monographs · doi:10.1093/jncimonographs/lgae035 · Cited by 7 · see citing works

Modeling the health and economic implications of adopting a 1-dose 9-valent human papillomavirus vaccination program in adolescents in low/middle-income countries: An analysis of Indonesia

Daniels, V., Saxena, K., Patterson‐Lomba, O., Gómez-Liévano, A., Thobari, J. A., Durand, N., & Myers, E. R. (2024) · PLoS ONE · doi:10.1371/journal.pone.0310591 · Cited by 6 · see citing works

Modeling the Health Impact and Cost-Effectiveness of a Combined Schoolgirl HPV Vaccination and Cervical Cancer Screening Program in Guangdong Province, China

Huang, Y., Zhang, D., Yin, L., Zhao, J., Li, Z., Lu, J., Zhang, X., Wu, C., & Wu, W. (2024) · Children · doi:10.3390/children11010103 · Cited by 6 · see citing works

A literature review and evidence-based evaluation of the Dutch national immunisation schedule yield possibilities for improvements

Pluijmaekers, A. J. M., Steens, A., Houweling, H., Rots, N. Y., Benschop, K., van Binnendijk, R. S., Bodewes, R., Brouwer, J. G. M., Buisman, A., Duizer, E., et al. (2024) · Vaccine X · doi:10.1016/j.jvacx.2024.100556 · Cited by 6 · see citing works

A novel C-terminal modification method enhanced the yield of human papillomavirus L1 or chimeric L1-L2 virus-like particles in the baculovirus system

Ma, M., Xia, B., Wang, Z., Hao, Y., Zhang, T., & Xu, X. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1073892 · Cited by 6 · see citing works

Human Papillomavirus Vaccines

Schiller, J. T., Markowitz, L. E., Kreimer, A. R., & Lowy, D. R. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-79058-1.00032-3 · Cited by 6 · see citing works

Acceptability of single-dose HPV vaccination schedule among health-care professionals in Kenya: a mixed-methods study

Umutesi, G., Weiner, B. J., Oluoch, L. M., Bukusi, E. A., Onono, M. A., Njoroge, B. W., Mecca, L., Ngure, K., Mugo, N., & Barnabas, R. V. (2024) · JNCI Monographs · doi:10.1093/jncimonographs/lgae031 · Cited by 5 · see citing works

Recommendations and guidance for human papillomavirus (HPV) vaccination for adults in Taiwan

Lin, K., Lin, I.-F., Wu, P.-F., Tsai, W.-C., Su, L.-Y., Chang, C.-N., Huang, W.-H., Wang, C.-H., Hung, M.-C., Huang, C.-H., et al. (2025) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2025.03.009 · Cited by 5 · see citing works

The Clinical Effectiveness of Single-Dose Human Papillomavirus Vaccination

Bao, W., He, X., Huang, Y., Liu, R., & Li, Z. (2024) · Vaccines · doi:10.3390/vaccines12090956 · Cited by 5 · see citing works

Prospects for Comprehensive Screening and Treatment of Cervical Cancer

Begliarzade, S., Mukhametova, R. R., & Zhao, B. (2024) · Creative Surgery and Oncology · doi:10.24060/2076-3093-2024-14-1-60-68 · Cited by 5 · see citing works

Key ethical considerations to guide the adjudication of a single-dose HPV vaccine schedule

Shadab, R., Lavery, J. V., McFadden, S. M., Elharake, J. A., Malik, F. A., & Omer, S. B. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2021.1917231 · Cited by 5 · see citing works

Parental Knowledge and Acceptance of HPV Vaccine in Rabigh’s School, Saudi Arabia

Alghanmi, R., Alkhalawi, E., Albeladi, R. S., Albeladi, S. M., Alghamdi, M., Fayoumi, A., & Nassif, R. A. (2026) · Annals of Global Health · doi:10.5334/aogh.4866 · Cited by 4 · see citing works

Human papillomavirus vaccination coverage among young women in the three sub-Saharan African countries using Demographic and Health Surveys data

Wassie, M., Zegeye, A. F., Mekonen, E. G., Tekeba, B., Ali, M. S., Gonete, A. T., Kassie, A. T., Workneh, B. S., Alemu, T. G., & Tamir, T. T. (2024) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2024.2370111 · Cited by 4 · see citing works

Exploring the complexity of the implementation determinants of human papillomavirus vaccination in Africa through a systems thinking lens: A rapid review

Adamu, A. A., Jalo, R. I., Ndwandwe, D. E., & Wiysonge, C. S. (2024) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2024.2381922 · Cited by 4 · see citing works

Immunogenicity and duration of antibodies after vaccination with a two-dose series of the nine-valent human papillomavirus vaccine among Alaska Native children: a prospective cohort study

Steinberg, J., Panicker, G., Unger, E. R., Blake, I., Lewis, R. M., Geis, J., Bruden, D. J. T., Fischer, M., Markowitz, L. E., & Bruce, M. G. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-10961-z · Cited by 3 · see citing works

Knowledge and acceptability of male HPV vaccination among young people and community stakeholders in northwest Tanzania: social sciences in the Add-Vacc trial

Kelly, S., Changalucha, J. M., Malibwa, D., Ewing, V., Mkungu, G., Deogratias, D., Hashim, R., Stanley, M., Lacey, C., Hayes, R., et al. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.128002 · Cited by 3 · see citing works

A single-injection vaccine providing protection against two HPV types

Zhang, J., Liu, Y., Guan, Y., & Zhang, Y. (2024) · Journal of Materials Chemistry B · doi:10.1039/d4tb00606b · Cited by 3 · see citing works

Human papillomavirus vaccine guideline adherence among Arizona’s Medicaid beneficiaries

Koskan, A. M., Klasko-Foster, L. B., Stecher, C. D., Rodríguez, S. A., Helitzer, D., & Yoo, W. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.12.041 · Cited by 3 · see citing works

La vaccinazione anti-papillomavirus: mai più senza!

Russo, R., & Marchetti, F. (2024) · Medico e Bambino · doi:10.53126/meb43575 · Cited by 3 · see citing works

Influences on male college students’ patient-provider communications and uptake behaviors related to the human papillomavirus vaccine

Koskan, A. M., Stecher, C. D., & Helitzer, D. (2022) · Journal of American College Health · doi:10.1080/07448481.2022.2086004 · Cited by 3 · see citing works

Different dose series of human papillomavirus vaccine in young females: a pair-wise meta-analysis and network meta-analysis from randomized controlled trials

Li, K., Mengpei, Z., Zeng, J., & Rutie, Y. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1152057 · Cited by 2 · see citing works

Evaluation of HPV-loaded PLGA microparticles as single-dose HPV vaccine: Insights for sustained-release vaccine development

Zhang, Y., Sullivan, N., Abraham, M., Haley, H., Liu, Y., Mahan, E., Hines, C. D. G., Tomaszewski, M. R., Miller, C. O., Bakthavatchalu, V., et al. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.127024 · Cited by 2 · see citing works

Immune response after one dose of HPV vaccine among girls and boys and the impact of a second dose given after 3 or more years

Guzun, N., Ouakki, M., Panicker, G., Ionescu, I. G., Mayrand, M., Unger, E. R., & Sauvageau, C. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.127475 · Cited by 2 · see citing works

Vaccination against human papillomavirus is a fundamental factor in the prevention of cervical cancer (review)

Enkova, E. V., Kiseleva, Е. V., Khoperskaya, O. V., Вячеславович, Ш. С., Dukhanina, E. S., & Sentsova, E. Y. (2021) · RESEARCH RESULTS IN BIOMEDICINE · doi:10.18413/2658-6533-2021-7-2-0-9 · Cited by 2 · see citing works

As barreiras das mulheres que fazem sexo com mulheres no acesso à saúde no Brasil

de Araújo, R. A. S., Oliveira, R. D. S., Dias, J. M. G., Fontes, G. D. Q., Silva, T. S. L. D. B., Gonçalves, A. S. S., & Albuquerque, A. A. (2021) · Research Society and Development · doi:10.33448/rsd-v10i17.23602 · Cited by 2 · see citing works

The Clinical Effectiveness of One-Dose HPV Vaccine: A meta-analysis of 902,368 vaccinated womenPreprint

Setiawan, D., Nurulita, N. A., Khoirunnisa, S. M., & Postma, M. J. (2023) · medRxiv · doi:10.1101/2023.08.17.23294214 · Cited by 2 · see citing works

Decoding impact of human papillomavirus in gynecological oncology: a narrative review

Sarker, M. S., & Pervez, M. M. (2025) · Obstetrics & Gynecology Science · doi:10.5468/ogs.24226 · Cited by 1 · see citing works

Human papillomavirus vaccination uptake among men who have sex with men living with HIV

Moran, C., García-Iglesias, J., & Kerr, C. (2025) · Sexually Transmitted Infections · doi:10.1136/sextrans-2024-056361 · Cited by 1 · see citing works

Long term immunogenicity of two doses of the quadrivalent HPV vaccine and the effect of an additional dose given five years post-primary vaccination

Sauvageau, C., Ionescu, I. G., Ouakki, M., Panicker, G., Unger, E. R., Gîlca, V., & Mayrand, M. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.127893 · Cited by 1 · see citing works

Long-term effectiveness of at least one dose of human papillomavirus vaccine in adolescents: A test-negative case–control study

Kamolratanakul, S., Niyom, S. L., Ayudaya, N. I. N., Ruengprasertkit, C., Horthongkham, N., Sripradit, K., Dhitavat, J., Muangnoicharoen, S., Sunthornchart, S., & Pitisuttithum, P. (2026) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2026.108489 · Cited by 1 · see citing works

Immunogenicity and Safety of One-Dose Human Papillomavirus Vaccine Compared With Two or Three Doses in Tanzanian Girls (DoRIS): An Open-Label, Randomised, Non-inferiority Trial

Watson‐Jones, D., Changalucha, J. M., Whitworth, H. S., Pinto, L. A., Mutani, P., Indangasi, J., Kemp, T. J., Hashim, R., Kamala, B., Wiggins, R. C., et al. (2023) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0000000000001135 · Cited by 1 · see citing works

Human papillomavirus vaccine

Rajaram, S., Sahoo, I., Heda, A., & SINGH, L. (2023) · Current Medicine Research and Practice · doi:10.4103/cmrp.cmrp_28_23 · Cited by 1 · see citing works

Quince años de vacunación frente al virus del papiloma humano en España. Actualización

Llop, F. A. M. (2023) · Vacunas · doi:10.1016/j.vacun.2023.05.001 · Cited by 1 · see citing works

Epigenetic Factor MicroRNAs Likely Mediate Vaccine Protection Efficacy against Lymphomas in Response to Tumor Virus Infection in Chickens through Target Gene Involved Signaling Pathways

Zhang, L., Xie, Q., Chang, S., Ai, Y., Dong, K., & Zhang, H. (2024) · Veterinary Sciences · doi:10.3390/vetsci11040139 · Cited by 1 · see citing works

Surveillance of High-Risk Type-16 and 18 Human Papillomavirus among HIV Positive and Non-Positive Individuals at Federal Teaching Hospital Ebonyi State Nigeria

Onu, E. N., Ilang, D. C., Azi, C. I., Eze, T. O., Akpa, C. O., Ogbonna, O. E., Agada, S. E., & Onwe, M. C. (2024) · Advances in Microbiology · doi:10.4236/aim.2024.1412045 · Cited by 1 · see citing works

Should the cervical dysplasia (CIN2+) recurrence nomogram be used for HPV vaccination triage after conization?

Tjalma, W. A. A. (2020) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000584 · Cited by 1 · see citing works

Neues zu Impfungen bei Erwachsenen

Seybold, U. (2020) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-0982-8894

Impfprävention HPV-assoziierter Neoplasien

Wieland, U., & Kreuter, A. (2022) · Forum · doi:10.1007/s12312-022-01063-x

Prävention HPV-induzierter Erkrankungen durch prophylaktische Impfung

Wieland, U., & Kreuter, A. (2022) · best practice onkologie · doi:10.1007/s11654-022-00372-w

Implementation of HPV vaccine worldwide and in Japan

Fujii, T. (2022) · 日本臨床細胞学会雑誌 · doi:10.5795/jjscc.61.227

Fifteen years of vaccination against the human papilloma virus in Spain. An update

Llop, F. A. M. (2023) · Vacunas (English Edition) · doi:10.1016/j.vacune.2023.10.001

Impacto da pandemia COVID-19 no rastreamento organizado de câncer de colo uterino com teste de DNA-HPV em Indaiatuba-SP

Polegatto, I. (2022) · doi:10.47749/t/unicamp.2022.1259071

The Impact of Human Immunodeficiency Virus on Women in the United States

Guillaume, D. (2024) · Nursing Clinics of North America · doi:10.1016/j.cnur.2024.01.003

The second generation of domestic HPV vaccine based on Escherichia coli expression system can induce high titer neutralizing antibodies

Zhu, K., Bi, Z., Chen, Q., Zhong, G., Wu, T., Zhang, J., & Xia, N. (2024) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2024-0880

Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to multidose vaccination regimens or no vaccination: An updated systematic review of evidence from clinical trials

Whitworth, H. S., Mounier‐Jack, S., Choi, E. M.-L., Gallagher, K. E., Howard, N., Kelly, H. A., Mbwanji, G., Kreimer, A. R., Basu, P. S., Barnabas, R. V., et al. (2024) · Vaccine X · doi:10.1016/j.jvacx.2024.100486 · Cited by 23 · see citing works

Comparative effectiveness and immunogenicity of single-dose and multi-dose human papillomavirus vaccination: a systematic review

Jeong, M., & Jang, I. (2025) · BMC Public Health · doi:10.1186/s12889-025-23496-4 · Cited by 7 · see citing works

The clinical effectiveness of one-dose vaccination with an HPV vaccine: A meta-analysis of 902,368 vaccinated women

Setiawan, D., Nurulita, N. A., Khoirunnisa, S. M., & Postma, M. J. (2024) · PLoS ONE · doi:10.1371/journal.pone.0290808 · Cited by 45 · see citing works

The Clinical Effectiveness of Single-Dose Human Papillomavirus Vaccination

Bao, W., He, X., Huang, Y., Liu, R., & Li, Z. (2024) · Vaccines · doi:10.3390/vaccines12090956 · Cited by 5 · see citing works

Efficacy of single-dose HPV vaccine over no vaccination and standard multiple dose regimen: a systematic review and meta-analysis of available evidence

Gupta, S., Basu, S., & Banerjee, R. (2024) · The Evidence · doi:10.61505/evidence.2024.2.2.71